"The Maze Runner 3: The Death Cure" will soon resume production as lead star Dylan O'Brien is recovering from his injury early this year. Contrary to rumors that he was being replaced, O'Brien will return to filming in February 2017.
Production for "The Maze Runner 3: The Death Cure" was postponed indefinitely after O'Brien got into a serious injury on set. The actor reportedly fractured his cheekbone and orbital socket during a stunt sequence that went wrong, Deadline reported. Months after the incident, the 25-year-old actor appears to be in better shape, as seen in a video that was shared on Twitter.
There were concerns about O'Brien's role in the film, especially after it was rumored that he would be replaced by a different actor or that his character, Thomas, would have a different appearance due to the actor's injuries. However, O'Brien seems to be doing very well considering that he is reportedly wrapping up filming for "The American Assassin" in which he stars as Mitch Rapp.
According to Deadline, O'Brien plays a CIA black ops recruit who is sent to investigate a wave of random attacks on military and civilian targets. Rapp and Stan Hurley (Michael Keaton) are then led to a joint mission with a Turkish agent (Shiva Negar) to apprehend an operative (Taylor Kitsch) that plans to initiate a world war in the Middle East.
O'Brien, to the relieve of fans, also stars in the currently on-air "Teen Wolf" Season 6 where he reprises his role as Stiles. The character is currently at the center of the supernatural mystery that has engulfed Beacon Hills. It is now up to his friends to rescue him, otherwise he will be forgotten for the rest of eternity.
"The Maze Runner 3: The Death Cure" will be directed by Wes Ball with the script written by T.S. Nowlin. The movie is based on the hit young adult fiction series written by James Dashner. The movie is the third and final film in the franchise and follows Thomas and his friends searching for a cure to the Flare.
"The Maze Runner 3: The Death Cure" premieres in theaters on Jan. 12, 2018.